OLMA
OlemaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
OLMA vs peer average
50/100
OLMA vs. peer average (C vs. C)
Grade spread
A 3 · B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ARVN is the first available peer comparator.
Arvinas is the closest public comparator because vepdegestrant is a competing ER-targeting program in ER+/HER2- metastatic breast cancer; Olema itself lists vepdegestrant as a competitive program in its 10-K.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
OLMA
Olema
ARVN
Arvinas
Grade
C
C
Momentum
9
8
Value
41
57
Sentiment
100
90
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs ARVN
OLMA / ARVN
Grade Position
In line
OLMA vs. peer average (C vs. C)
50/100
Momentum
9
OLMAValue
41
ARVNSentiment
100
OLMARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs OLMA
ARVN is the first peer returned for this comparison set.